None

Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets

Tablets from the affected lot may exceed the weight specification and could be super-potent for the ingredients Hydrocodone Bitartrate and Acetaminophen.

Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets

Audience: Consumer, Health Professional Qualitest/Endo Health Mylan UPDATE 12/21/2012: Mylan announced a voluntary nationwide recall to the retail level of three lots of Hydrocodone Bitartrate and A...

Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets

Audience: Consumer, Health Professional ISSUE: Qualitest, a subsidiary of Endo Health Solutions, issued a voluntary nationwide recall for 101 lots of Hydrocodone Bitartrate and Acetaminophen Tablets,...

Voluntary Product Recall Initiated by Qualitest Pharmaceuticals Impacts Three Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Repackaged and Distrib...

Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business is conducting a voluntary nationwide recall to the retail level of three lots of Hydrocodone Bitartrate and Acetaminophen...

Hydrocodone/Acetaminophen Tablets Recalled

Watson Laboratories is recalling about 4800 bottles of hydrocodone bitartrate and acetaminophen tablets because of the potential for oversized and superpotent tablets. News Alerts

Mylan voluntarily recalls hydrocodone tablets

Mylan Inc. said Thursday that it is voluntarily recalling three lots of a painkiller tablet because of the risk that it may exceed the appropriate potency.The hydrocodone bitartrate and acetaminophen...

Zohydro ER hydrocodone bitartrate regulatory update

FDA panel backs tougher restrictions for hydrocodone products

FDA's Drug Safety and Risk Management Advisory Committee voted 19-10 on Friday that the U.S. Drug Enforcement Administration (DEA) reschedule hydrocodone combination products as class II scheduled dru...

Anomalous observations of hydrocodone in patients on oxycodone.

BACKGROUND: Urine drug monitoring is used by physicians treating chronic pain patients with opioid therapy. Patients are tested in part to insure that they are not taking other drugs. Therefore, the f...

Hydrocodone and morphine possess similar rewarding effects and reduce ERK and CREB phosphorylation in the nucleus accumbens.

The number of prescriptions for hydrocodone-containing opioid analgesics has greatly increased over the past decade. This increase has led to an associated enhancement in the non-medical use of hydroc...

Update on hydrocodone metabolites in rats and dogs aided with a semi-automatic software for metabolite identification Mass-MetaSite.

1. There has been a lack of in vivo metabolite profiling update of hydrocodone since the original report on species differences was published in 1978. As such, the mechanism for its analgesic activity...

Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions.

Fatal opioid toxicity occurred in a developmentally delayed child aged 5 years 9 months who was inadvertently administered high doses of hydrocodone for a respiratory tract infection. The concentratio...

Therapy: An extended-release form of cysteamine bitartrate for cystinosis.